Austin, Texas, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Diagnostics Market Size & Growth Analysis:
According to SNS Insider, The Diagnostics Market was valued at USD 312.84 Billion in 2025 and is expected to reach USD 539.07 Billion by 2035, growing at a CAGR of 5.62% from 2026 to 2035. Growth in the market is attributed to the increasing incidence of chronic diseases coupled with increasing utilization of precision diagnostics as healthcare organizations move towards early and accurate detection of diseases to ensure better clinical outcomes and reduce treatment costs.
Technologies related to molecular diagnostics and digital diagnostic tests have been contributing immensely in this context as they enable the advancement in test procedures and increase their capabilities in the fields of infectious diseases and oncology.
Download the Diagnostics Market Sample Report: https://www.snsinsider.com/sample-request/10405
Diagnostics Market Key Highlights
- Market size, 2025: USD 312.84 Billion
- Market forecast, 2035: USD 539.07 Billion
- CAGR: 5.62% from 2026 to 2035
- Largest region: North America, approximately 32.16% share in 2025
- Asia Pacific share: approximately 28.12% of global revenue in 2025
- Largest product type: In Vitro Diagnostics (IVD), approximately 43.00% share in 2025
- Fastest-growing product type: Molecular Diagnostics
- Largest application: Infectious Diseases, approximately 27.00% share in 2025
- Fastest-growing application: Oncology
- Largest technology: Immunodiagnostics, approximately 31.00% share in 2025
- Fastest-growing technology: Digital Diagnostics
- Largest end user: Hospitals & Clinics, approximately 46.00% share in 2025
- Fastest-growing end user: Home Care Settings
Market Relevance
Diagnostic testing plays a pivotal role right in the front for almost every clinical decision-making process, which involves determining treatment plans, monitoring progress, and intervening in time. Increased incidence rates of chronic diseases, together with a greater focus on precision medicine, is resulting in an increase in testing volume and complexity.
Diagnostics Market Overview
The market is made up of in vitro diagnostics and molecular diagnostics that have been created using immunodiagnostic and digital diagnostic technology in various applications in the infectious diseases and oncology clinical specialties. In vitro diagnostics is the major product offering, since it is widely used in clinical applications. This is due to the number of routine laboratory testing and point-of-care tests that it offers, while molecular diagnostics is growing rapidly due to its increased sensitivity and specificity in the detection of pathogens and genes.
Strategic Market Outlook
Growth opportunities include the evolution of the molecular and digital diagnostics into the rapidly expanding field of oncology, where early and more accurate detection impacts patient outcomes significantly. An additional growth area involves home care testing, as new formats of tests become available that can be performed at home.
Pricing pressure and regulatory compliance are key restraints. Pricing of diagnostic tests will continue to face downward pressure in major healthcare systems, while regulatory validation requirements increase the costs and lengthen the time to market, especially when multiple jurisdictions are targeted for certification.
Diagnostics Market Regional Analysis
North America dominated the global market in 2025, holding approximately 32.16% of global revenues, supported by advanced laboratory infrastructure, high testing volumes, and early adoption of molecular and precision diagnostic technologies. The United States accounted for approximately 80.50% of North American revenue.
The U.S. Diagnostics Market was valued at USD 80.99 Billion in 2025 and is expected to reach USD 123.60 Billion by 2035, growing at a CAGR of 4.35% from 2026 to 2035.
The Europe Diagnostics Market held approximately 30.87% of the global market in 2025, valued at USD 96.57 Billion, and is expected to reach USD 161.09 Billion by 2035, growing at a CAGR of 5.25% from 2026 to 2035. Germany accounted for approximately 25.20% of European revenue in 2025, supported by its established diagnostics manufacturing and laboratory infrastructure.
The Asia-Pacific region accounted for approximately 28.12% of global diagnostics market revenue in 2025, supported by expanding laboratory capacity and growing testing access across the region. China accounted for approximately 39.80% of regional revenue.
Middle East & Africa: The UAE accounted for approximately 29.00% of regional revenue in 2025.
Latin America: Brazil led regional revenue at approximately 44.50% in 2025.
Buy the Diagnostics Market Report with Competitive Analysis at a 20% Discount: https://www.snsinsider.com/checkout/10405
Diagnostics Market Segment Analysis
By Product Type: Market Share of In Vitro Diagnostics was 43.00% in 2025 due to high volumes of routine laboratory and Point of Care tests. Molecular Diagnostics is the most rapidly growing segment in terms of product type until 2035 owing to better sensitivity and specificity in pathogen and genetic testing.
By Application: The market share held by Infectious Diseases was 27.00% in 2025 because of consistent global testing needs in pathogen detection and surveillance. The application with highest CAGR through 2035 is Oncology, fueled by growing cases of cancer and increasing need for early diagnosis and companion diagnostics.
By Technology: Immunodiagnostic technologies held a market share of approximately 31.00% in 2025, underpinned by existing, high throughput test menus within clinical labs. Digital diagnostics is expected to be the highest growing technology up to 2035, propelled by software-based analysis, connectivity, and decentralization of testing
By End User: The Hospitals & Clinics segment has 46.00% market share in 2025, considering the volume of diagnostic tests conducted and lab facilities within them. The Home Care Settings are set to be the fastest-growing end-users till 2035, owing to rising cases of self-testing.
Diagnostics Market Key Trends
- Rising chronic disease prevalence sustaining growth in global diagnostic testing volumes
- Increasing adoption of precision diagnostics enabling earlier and more targeted clinical intervention
- Growing shift toward molecular diagnostic platforms offering higher sensitivity and specificity
- Expanding oncology diagnostic investment driven by rising cancer incidence and companion testing
- Accelerating decentralization of testing into clinics and home care settings
Competitive Landscape
The Diagnostics Market includes established global diagnostics leaders alongside specialized molecular, immunoassay, and sequencing technology providers, with competition centred on assay menu breadth, platform automation, and expansion into decentralized and precision testing applications.
Major key players include
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Siemens Healthineers AG
- Danaher Corporation
- Becton, Dickinson and Company
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN N.V.
- Sysmex Corporation
- Hologic, Inc.
- Agilent Technologies, Inc.
- bioMérieux SA
- Illumina, Inc.
- PerkinElmer Inc.
- QuidelOrtho Corporation
- Mindray Medical International Limited
- FUJIFILM Holdings Corporation
- Werfen S.A.
- Sekisui Medical Co., Ltd.
- DiaSorin S.p.A.
Explore the Complete Diagnostics Market Report: https://www.snsinsider.com/reports/diagnostics-market-10405
